Internal Medicine, Hematology & Oncology · Torrance, CA
NPI
1053846485
Since 2017
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
23600 Telo Ave Ste 260
Torrance, CA, 90505
Phone (424) 435-1037
Groups this clinician bills Medicare through
Medicare paid, 2024
$559K
32,254 services
Medicare patients, 2024
219
Average age 76
Drug cost, 2024
$7.5M
2,848 prescriptions
Company payments, 2025
$7,931
From 57 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael H Nguyen was code J1437 (injection, ferric derisomaltose, 10 mg), 1,900 times for 17 patients. In total Michael H Nguyen billed 32,254 services in 68 codes, and Medicare paid $559K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,900 | 17 | $15.75 | $30K |
| 99233 Hospital E&M - Subsequent | Facility | 316 | 96 | $96.78 | $31K |
| 99232 Hospital E&M - Subsequent | Facility | 308 | 90 | $64.61 | $20K |
| 99215 Office E&M - Established | Office | 231 | 68 | $150.67 | $35K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 150 | 79 | $13.52 | $2,028 |
| 99223 Hospital E&M - Initial | Facility | 135 | 105 | $141.77 | $19K |
| 96367 Intravenous Infusion, Hydration | Office | 121 | 12 | $25.53 | $3,089 |
| 96413 Chemotherapy Administration | Office | 96 | 13 | $117.77 | $11K |
| 99214 Office E&M - Established | Office | 61 | 38 | $104.47 | $6,373 |
| 99205 Office E&M - New | Office | 49 | 49 | $179.01 | $8,772 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 24 | 17 | $27.13 | $651 |
| 96365 Intravenous Infusion, Hydration | Office | 22 | 20 | $54.49 | $1,199 |
By year: 2023 $16K for 416 services; 2024 $559K for 32,254 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael H Nguyen prescribed most often to Medicare patients was Anastrozole, with 188 prescriptions and refills. In total Michael H Nguyen wrote 2,848 Medicare prescriptions that cost $7.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 188 | 490 | 63 | $3,964 |
| Prednisone Generic | 159 | 191 | 30 | $890 |
| Ondansetron Hcl Ondansetron Hcl/Pf | 150 | 150 | 38 | $195 |
| Abiraterone Acetate Generic | 142 | 148 | 19 | $374K |
| Dexamethasone Sodium Phosphate Generic | 127 | 139 | 33 | $414 |
| Ondansetron Odt Ondansetron | 107 | 109 | 71 | $1,284 |
| Dexamethasone Generic | 100 | 117 | 37 | $2,079 |
| Famotidine Famotidine/Pf | 99 | 110 | 27 | $88.85 |
| Diphenhydramine Hcl Generic | 95 | 107 | 27 | $162 |
| Zarxio Filgrastim-Sndz | 87 | 87 | 19 | $101K |
| Loperamide Loperamide Hcl | 81 | 81 | 49 | $855 |
| Eliquis Apixaban | 66 | 112 | 21 | $63K |
| Letrozole Generic | 65 | 179 | 22 | $2,100 |
| Oxaliplatin Generic | 65 | 65 | 15 | $6,406 |
| Zoledronic Acid Generic | 64 | 80 | 14 | $3,089 |
Brand drugs: 827 claims; generic drugs: 2,021 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael H Nguyen $7,931 ($7,931 in general payments such as food, travel and fees) from 57 companies. The largest payer was Pfizer Inc. with $710.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 27 | $710 |
| AstraZeneca Pharmaceuticals LP AZN | 20 | $569 |
| Novartis Pharmaceuticals Corporation NVS | 28 | $553 |
| Incyte Corporation INCY | 16 | $432 |
| BeOne Medicines USA, Inc. ONC | 13 | $384 |
| Janssen Biotech, Inc. JNJ | 17 | $383 |
| Merck Sharp & Dohme LLC MRK | 11 | $311 |
| Astellas Pharma US Inc 4503.T | 11 | $277 |
| Abbvie Inc. ABBV | 10 | $263 |
| Gilead Sciences, Inc. GILD | 12 | $248 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.